Adjunctive pharmacologic treatment: Focus on the development of low molecular weight heparins
Publication
, Journal Article
Becker, RC; Spencer, F
Published in: Journal of Thrombosis and Thrombolysis
1997
Duke Scholars
Published In
Journal of Thrombosis and Thrombolysis
DOI
Publication Date
1997
Volume
4
Issue
2
Start / End Page
197 / 206
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C., & Spencer, F. (1997). Adjunctive pharmacologic treatment: Focus on the development of low molecular weight heparins. Journal of Thrombosis and Thrombolysis, 4(2), 197–206. https://doi.org/10.1023/A:1008870228789
Becker, R. C., and F. Spencer. “Adjunctive pharmacologic treatment: Focus on the development of low molecular weight heparins.” Journal of Thrombosis and Thrombolysis 4, no. 2 (1997): 197–206. https://doi.org/10.1023/A:1008870228789.
Becker RC, Spencer F. Adjunctive pharmacologic treatment: Focus on the development of low molecular weight heparins. Journal of Thrombosis and Thrombolysis. 1997;4(2):197–206.
Becker, R. C., and F. Spencer. “Adjunctive pharmacologic treatment: Focus on the development of low molecular weight heparins.” Journal of Thrombosis and Thrombolysis, vol. 4, no. 2, 1997, pp. 197–206. Scival, doi:10.1023/A:1008870228789.
Becker RC, Spencer F. Adjunctive pharmacologic treatment: Focus on the development of low molecular weight heparins. Journal of Thrombosis and Thrombolysis. 1997;4(2):197–206.
Published In
Journal of Thrombosis and Thrombolysis
DOI
Publication Date
1997
Volume
4
Issue
2
Start / End Page
197 / 206
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences